表紙
市場調查報告書

2020-2025年全球數字療法和數字健康市場

Digital Therapeutics & Wellness: Disruption, Innovation Opportunities & Market Size 2020-2025

出版商 Juniper Research Ltd 商品編碼 968821
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
2020-2025年全球數字療法和數字健康市場 Digital Therapeutics & Wellness: Disruption, Innovation Opportunities & Market Size 2020-2025
出版日期: 2020年10月27日內容資訊: 英文
簡介

本報告調查了全球數字療法和數字健康市場,包括市場前景和狀況,包括心血管疾病和高血壓,糖尿病和糖尿病前期,肥胖和體重減輕以及加拿大戒菸。 它提供的信息包括對主要市場(如中國,德國,日本,英國和美國)的分析以及對主要公司的分析。

本報告解決的主要問題

  • 1. 目前的市場狀態是什麼?
  • 2. COVID-19有什麼作用?
  • 3. 您的主要研發領域是什麼?
  • 4. 最大的問題是什麼?
  • 5. 在未來五年中,點差和利潤趨勢將如何變化?

本報告中介紹的公司

2Morrow、7Cups、Aaptiv、Aetna、Akili Interactive Labs、American College of Cardiology、Apple、AppliedVR、AstraZeneca、Aura、Babylon Health、Better Therapeutics、Big Health、Bloom、Blue Mesa Health、Brain Power、Calm、Care NI、 Centers for Medicare and Medicaid Services、CIDRAP(Center for Infectious Disease 調查 and Policy)、Cigna、Click Therapeutics、Department of Health and Human Services、DHCE(Digital Health Center of Excellence)、Digital Health、Digital Therapeutics Alliance、Drug Enforcement Administration( DEA)、FDA(Food and Drug Administration)、Fitbit、Fitness Buddy、Garmin、Ginger.io、Glytec、Google、GOQii、Headspace、Heartbeat Heart、Hello Heart、Humana、Insight Timer、International Diabetes Foundation、John Hancock、Kiio、 Livongo、Lose It!、MapMyRun、Medullan、Meru Health、Mira、My mлюЗ、MyFitnessPal、NHS(National Health Service)、NICE(National Institute for Health and Care Excellence)、Nicotrax、Omada、Omron、Propeller Health、Quit Genius、 Sanvello、Sl eepio、Somnox、Strava、Teladoc、The Mindfulness App、Under Armour、Vida Health、Virgin Pulse、Virta Health、Vitality、Voluntis、Welldoc、Wellthy Therapeutics

目錄

第1章2020年及以後的前景

  • 簡介
  • 定義
  • 調查範圍
  • 預測方法
  • 數字療法和醫學的未來
  • 數字健康和自我保健的未來
  • COVID-19對數字治療的影響
  • COVID-19對數字健康的影響
  • 市場前景

第2章數字療法市場狀況

  • 簡介
  • 數字療法的發展
  • 數字治療學價值鏈
  • 數字治療業務模型
  • 評估數字療法的顛覆性變化
    • 心血管疾病和高血壓
    • 糖尿病和體重減輕
    • 禁止吸煙
    • 心理健康與發育障礙

第3章數字健康市場狀況

  • 簡介
  • 數字健康發展
  • 健康應用和設備價值鏈
  • 數字健康業務模型
  • 數字健康破壞性評估
    • 情緒健康
    • 運動和減肥教練
  • 數字健康市場預測
    • 數字健康用戶預測
    • 數字健康收入預測
目錄

Juniper Research's new ‘Digital Therapeutics & Wellness’ research provides an in-depth assessment of the evolving requirements, capabilities, and market landscape of these disruptive technologies. This essential guide provides detailed analysis and forecasts for the following key segments:

  • Cardiovascular Disease & Hypertension
  • Diabetes & Prediabetes
  • Obesity & Weight Loss
  • Smoking Cessation
  • Other Digital Therapeutics
  • Digital Consumer Wellness
  • Digital Corporate Wellness

The research includes:

  • Market Trends & Opportunities (PDF)
  • 5-Year Market Sizing & Forecast Spreadsheet (Excel)

Key Features

  • Market Landscape: Strategic assessment of key trends and considerations for digital therapeutics players and investors; covering all aspects from product design and development to deployment and usage.
  • Benchmark Industry Forecasts: Forecasts providing adoption rates, subscription costs and total revenue for each of the following segments:
    • Cardiovascular Disease & Hypertension
    • Diabetes & Prediabetes
    • Obesity & Weight Loss
    • Smoking Cessation
    • Other Digital Therapeutics
    • Digital Consumer Wellness
    • Digital Corporate Wellness
  • Key Takeaways & Strategic Recommendations: Evaluation and strategic guidance on product development and factors affecting the use of digital therapeutics and wellness, segment by segment.
  • Juniper Research Disruptors & Innovators Quadrants: Analysis of key players in the digital therapeutics and wellness industries, including:
    • Cardiovascular Disease & Hypertension
      • Better Therapeutics
      • Heartbeat Health
      • Livongo
      • My mHealth
      • Omada Health
      • Vida Health
      • Wellthy Therapeutics
    • Diabetes & Prediabetes
      • Livongo
      • My mHealth
      • Omada Health
      • Vida Health
      • Virgin Pulse
      • Virta Health
      • Voluntis
      • Welldoc
    • Smoking Cessation
      • 2Morrow
      • Click Therapeutics
      • NHS Smokefree
      • Nicotrax
      • Quit Genius
      • Vida Health
      • Mental Health & Developmental Disorders
      • Akili Interactive
      • AppliedVR
      • Brain Power
      • Ginger.io
      • Meru Health
      • Sanvello
      • Sleepio
    • Emotional Health
      • 7 Cups
      • Aura
      • Calm
      • Headspace
      • Insight Timer
      • Somnox
      • The Mindfulness App
    • Exercise & Weight Loss Coaching
      • Fitbit
      • Fitness Buddy
      • Lose It!
      • MapMyRun
      • MyFitnessPal
      • Strava
      • Weight Watchers

Key Questions

  • 1. What is the current state of digital therapeutics and wellness?
  • 2. How has COVID-19 affected digital therapeutics and wellness?
  • 3. What are the key areas of research and development in digital therapeutics and wellness?
  • 4. What are the biggest issues in digital therapeutics and wellness?
  • 5. How will digital therapeutics and wellness adoption, usage, and revenue grow over the next five years?

Companies Referenced

Mentioned: 2Morrow, 7Cups, Aaptiv, Aetna, Akili Interactive Labs, American College of Cardiology, Apple, AppliedVR, AstraZeneca, Aura, Babylon Health, Better Therapeutics, Big Health, Bloom, Blue Mesa Health, Brain Power, Calm, Care NI, Centers for Medicare and Medicaid Services, CIDRAP (Center for Infectious Disease Research and Policy), Cigna, Click Therapeutics, Department of Health and Human Services, DHCE (Digital Health Center of Excellence), Digital Health, Digital Therapeutics Alliance, Drug Enforcement Administration (DEA), FDA (Food and Drug Administration), Fitbit, Fitness Buddy, Garmin, Ginger.io, Glytec, Google, GOQii, Headspace, Heartbeat Heart, Hello Heart, Humana, Insight Timer, International Diabetes Foundation, John Hancock, Kiio, Livongo, Lose It!, MapMyRun, Medullan, Meru Health, Mira, My mHealth, MyFitnessPal, NHS (National Health Service), NICE (National Institute for Health and Care Excellence), Nicotrax, Omada, Omron, Propeller Health, Quit Genius, Sanvello, Sleepio, Somnox, Strava, Teladoc, The Mindfulness App, Under Armour, Vida Health, Virgin Pulse, Virta Health, Vitality, Voluntis, Welldoc, Wellthy Therapeutics, World Bank, World Health Organisation, WW.

Data & Interactive Forecast

Juniper Research's ‘Digital Therapeutics & Wellness’ forecast suite includes:

  • Data splits for 8 key global regions in addition to country breakdowns for:
    • Canada
    • China
    • Germany
    • Japan
    • UK
    • US
  • Total digital therapeutics addressable market, split by:
    • Total sufferers of all named conditions
    • All seeking treatment
    • All seeking treatment with digital therapeutics
  • Total consumer wellness addressable market, split by:
    • Number of smartphones with wellness apps installed
    • Number of wellness apps per smartphone
    • Number of wellness apps installed base
    • Number of wellness apps monetised per annum
  • Total corporate wellness addressable market, split by:
    • Number of workers covered by digital corporate wellness programmes
    • Average spend per worker per annum on digital corporate wellness programmes
  • Total digital therapeutics and wellness revenue, split by application:
    • Cardiovascular Disease & Hypertension
    • Diabetes & Prediabetes
    • Obesity & Weight Loss
    • Smoking Cessation
    • Other Digital Therapeutics
    • Digital Consumer Wellness
    • Digital Corporate Wellness
  • Interactive Scenario Tool allowing users to manipulate Juniper Research's data for 50 different metrics.
  • Access to the full set of forecast data comprising of 310 tables and over 27,000 datapoints.

Juniper Research's highly granular interactive Excels enable clients to manipulate Juniper Research's forecast data and charts to test their own assumptions using the Interactive Scenario Tool, and compare select markets side by side in customised charts and tables. IFxls greatly increase clients' ability to both understand a particular market and to integrate their own views into the model.

Table of Contents

1. Digital Therapeutics & Wellness: 2020 and Beyond

  • 1.1 Introduction
  • 1.2 Definitions
    • 1.2.1 Digital Therapeutics Definition
    • 1.2.2 Digital Wellness Definition
      • Figure 1.1: Digital Wellness and Digital Therapeutics Segment Overlap
  • 1.3 Research Scope
    • 1.3.1 Digital Therapeutics
    • 1.3.2 Digital Wellness
  • 1.4 Forecast Methodologies
    • 1.4.1 Digital Therapeutics
      • Figure 1.2: Digital Therapeutics Forecast Methodology
    • 1.4.2 Consumer Digital Wellness
      • Figure 1.3: Consumer Digital Wellness Forecast Methodology
    • 1.4.3 Corporate Digital Wellness
      • Figure 1.4: Corporate Digital Wellness Forecast Methodology
  • 1.5 Digital Therapeutics & the Future of Medicine
    • 1.5.1 Clinical Testing and Validation
      • Figure 1.5: Proposed Component of the FDA's Pre-Cert Program
    • 1.5.2 Limitations of Digital Therapeutics
      • i. The Behaviour Problem
      • ii. Biases of Machine Leaning and AI Programmes
  • 1.6 Digital Wellness & the Future of Self-care
    • 1.6.1 Sales Channels
      • Figure 1.6: In-app Advertisement for Fitbit Premium
  • 1.7 The Impact of COVID-19 on Digital Therapeutics
    • 1.7.1 Increased Usage of Digital Therapeutics
    • 1.7.2 COVID-19-specific Digital Therapeutics
    • 1.7.3 Deregulation of Digital Therapeutics in the US
  • 1.8 The Impact of COVID-19 on Digital Wellness
  • 1.9. Market Outlook: Juniper's Research's View
    • 1.9.1 The Future of Digital Therapeutics
      • i. Medical Validation & the Path to Market
      • ii. The Portals and Integration Challenge
      • iii. The Long-term Effects of COVID-19
    • 1.9.2 Digital Therapeutics: Usage Forecasts
      • Figure & Table 1.8: Digital Therapeutics Users per annum (m), Split by 8 Key Regions, 2020-2025
    • 1.9.3 The Future of Digital Wellness
    • 1.9.4 Digital Wellness: Adoption Forecasts
      • Figure & Table 1.9: Number of Wellness Apps in Use per annum (m), Split by 8 Key Regions, 2018-2023
  • 1.9. Market Outlook: Juniper Research's View
    • Figure 1.7: Two Possible COVID-19 Wave Scenarios

2. Digital Therapeutics Market Status

  • 2.1 Introduction
  • 2.2 Digital Therapeutics Development
    • Figure 2.1: Digital Therapeutics Development Timeline
      • 2.2.1 Modular Platforms
  • 2.3 Digital Therapeutics Value Chain
    • Figure 2.2: Digital Therapeutics Value Chain
  • 2.4 Digital Therapeutics Business Models
    • 2.4.1 Business Model for Digital Therapeutics Providers
      • i. The Reimbursement Problem
      • ii. Data Usage
    • 2.4.2 Business Model for Systems Integrators
      • i. User Interfaces & Software Design
    • 2.4.3 Business Model for the Consumer Market
    • 2.4.4 Business Model for Health Insurance Companies
      • i. Acquisition or Integration?
  • 2.5 Digital Therapeutics Disruption Assessment
    • Figure 2.3: Juniper Strategy Quadrant for Digital Therapeutics
    • 2.5.1 Juniper R Criteria
    • 2.5.2 CVD & Hypertension Market Landscape & Outlook
      • i. Player Analysis & Positioning
        • Figure 2.4: Juniper's Research's Disruptors & Challenge's Quadrant for CVD & Hypertension
      • ii. Cardiovascular Disease Digital Therapeutics Users Forecast
        • Figure & Table 2.5: Cardiovascular Disease & Hypertension Digital Therapeutics Users per annum (m), Split by 8 Key Regions, 2020-2025
    • 2.5.3 Diabetes & Weight Loss Market Landscape & Outlook
      • i. Player Analysis & Positioning
        • Figure 2.6: Juniper's Research's Disruptors & Challenge's Quadrant for Diabetes & Weight Loss
      • ii. Diabetes Digital Therapeutics User Forecast
        • Figure & Table 2.7: Diabetes Digital Therapeutics Users per annum (m), Split by 8 Key Regions, 2020-2025
      • iii. Weight Loss Digital Therapeutics User Forecast
        • Figure & Table 2.8: Weight Loss Digital Therapeutics Users per annum (m), Split by 8 Key Regions, 2020-2025
    • 2.5.4 Smoking Cessation Market Landscape & Outlook
      • i. Player Analysis & Positioning
        • Figure 2.9: Juniper's Research's Disruptors & Challenge's Quadrant for Smoking Cessation Digital Therapeutics
      • ii. Smoking Cessation Digital Therapeutics User Forecast
        • Figure & Table 2.10: Smoking Cessation Digital Therapeutics Users per annum (m), Split by 8 Key Regions, 2020-2025
    • 2.5.5 Mental Health & Developmental Disorders Market Landscape & Outlook
      • i. Player Analysis & Positioning
        • Figure 2.6: Juniper's Research's Disruptors & Challenge's Quadrant for Mental & Health & Development Disorders Digital Therapeutics
    • 2.5.6 Other Digital Therapeutics Forecast
      • Figure & Table 2.12: Other Digital Therapeutics Users per annum (m), Split by 8 Key Regions, 2019-2024

3. Digital Wellness Market Status

  • 3.1 Introduction
  • 3.2 Wellness Development
    • 3.2.1 Diversification
  • 3.3 Wellness Apps & Devices Value Chain
    • Figure 3.1: Digital Wellness Value Chain
  • 3.4 Digital Wellness Business Models
    • 3.4.1 Business Model for Digital Wellness Software Providers
      • i. B2C Digital Wellness
      • ii. B2C Digital Wellness
    • 3.4.2 Business Model for Digital Wellness Hardware Providers
    • 3.4.3 Business Model for Health Insurers
  • 3.5 Digital Wellness Disruption Assessment
    • 3.5.1 Juniper's Research's Disruptors & Challenge's Quadrant Criteria
    • 3.5.2 Emotional Health Market Landscape & Outlook
      • Figure 3.2: Juniper's Research's Disruptors & Challenge's Quadrant for Emotional & Health Providers
    • 3.5.3 Exercise & Weight Loss Coaching Market Landscape & Outlook
      • Figure 3.3: Juniper's Research's Disruptors & Challenge's Quadrant for Exercise & Weight Loss Coaching Providers
  • 3.6 Digital Wellness Forecast
    • 3.6.1 Digital Wellness Users Forecast
      • Figure & Table 3.4: Number of Digital Wellness App Users per annum, Split by 8 Key Regions (m), 2020-2025
    • 3.6.2 Digital Wellness Revenue Forecast
      • Figure & Table 3.5: Digital Wellness App Revenue per annum, Split by 8 Key Regions (m), 2020-2025